- Home
- DLB
as of 03-09-2026 3:40pm EST
$65.27
+$0.06
+0.09%
Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.
| Founded: | 1965 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 6.5B | IPO Year: | 2004 |
| Target Price: | $90.75 | AVG Volume (30 days): | 742.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | Dividend Payout Frequency: | semi-annual | |
| EPS: | 0.55 | EPS Growth: | -2.60 |
| 52 Week Low/High: | $60.14 - $83.25 | Next Earning Date: | 04-30-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 6.22% | Revenue Growth (next year): | 3.84% |
| P/E Ratio: | 118.56 | Index: | N/A |
| Free Cash Flow: | 435.9M | FCF Growth: | -2.26% |
Stock Insider Trading Activity of Dolby Laboratories (DLB)
Revankar Shriram
Sell
SVP, Advanced Technology Group
DLB Feb 17, 2026
Avg Cost/Share
$66.14
Shares
3,000
Total Value
$198,420.00
Owned After
83,218
SEC Form 4
Nicholson Ryan
Sell
VP, CAO and Corp. Controller
DLB Feb 13, 2026
Avg Cost/Share
$66.38
Shares
2,667
Total Value
$177,022.66
Owned After
36,956
SEC Form 4
Couling John D
Sell
SVP, Entertainment
DLB Feb 2, 2026
Avg Cost/Share
$64.89
Shares
6,667
Total Value
$432,588.30
Owned After
123,041
SEC Form 4
YEAMAN KEVIN J
Sell
President and CEO
DLB Dec 17, 2025
Avg Cost/Share
$67.39
Shares
6,751
Total Value
$453,928.55
Owned After
98,457
SHERMAN MARK ANDREW
Sell
EVP, Gen. Counsel & Secretary
DLB Dec 17, 2025
Avg Cost/Share
$67.26
Shares
2,491
Total Value
$167,553.88
Owned After
70,563
SEC Form 4
YEAMAN KEVIN J
Sell
President and CEO
DLB Dec 16, 2025
Avg Cost/Share
$66.90
Shares
26,766
Total Value
$1,786,309.81
Owned After
98,457
SHERMAN MARK ANDREW
Sell
EVP, Gen. Counsel & Secretary
DLB Dec 16, 2025
Avg Cost/Share
$66.87
Shares
9,109
Total Value
$607,849.00
Owned After
70,563
Couling John D
Sell
SVP, Entertainment
DLB Dec 11, 2025
Avg Cost/Share
$68.75
Shares
7,273
Total Value
$500,018.75
Owned After
123,041
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Revankar Shriram | DLB | SVP, Advanced Technology Group | Feb 17, 2026 | Sell | $66.14 | 3,000 | $198,420.00 | 83,218 | |
| Nicholson Ryan | DLB | VP, CAO and Corp. Controller | Feb 13, 2026 | Sell | $66.38 | 2,667 | $177,022.66 | 36,956 | |
| Couling John D | DLB | SVP, Entertainment | Feb 2, 2026 | Sell | $64.89 | 6,667 | $432,588.30 | 123,041 | |
| YEAMAN KEVIN J | DLB | President and CEO | Dec 17, 2025 | Sell | $67.39 | 6,751 | $453,928.55 | 98,457 | |
| SHERMAN MARK ANDREW | DLB | EVP, Gen. Counsel & Secretary | Dec 17, 2025 | Sell | $67.26 | 2,491 | $167,553.88 | 70,563 | |
| YEAMAN KEVIN J | DLB | President and CEO | Dec 16, 2025 | Sell | $66.90 | 26,766 | $1,786,309.81 | 98,457 | |
| SHERMAN MARK ANDREW | DLB | EVP, Gen. Counsel & Secretary | Dec 16, 2025 | Sell | $66.87 | 9,109 | $607,849.00 | 70,563 | |
| Couling John D | DLB | SVP, Entertainment | Dec 11, 2025 | Sell | $68.75 | 7,273 | $500,018.75 | 123,041 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Jan 29, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYJan 29, 2026 · 100% conf.
AI Prediction BUY
1D
+7.92%
$68.02
5D
+7.18%
$67.55
20D
+4.17%
$65.66
Price: $63.03 Prob +5D: 100% AUC: 1.000
0001193125-26-029373
8-K
false 0001308547 0001308547 2026-01-29 2026-01-29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 29, 2026
DOLBY LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
Delaware
001-32431
90-0199783
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
1275 Market Street San Francisco, CA 94103-1410 (Address of principal executive offices) (Zip Code) (415) 558-0200 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A common stock, $0.001 par value
DLB
The New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Section 2 - Financial Information ITEM 2.02 Results of Operations and Financial Condition. The following information is intended to be furnished under Item 2.02 of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On January 29, 2026, Dolby Laboratories, Inc. (the “Company”) issued a press release announcing its financial results for its fiscal quarter ended December 26, 2025. The full text of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference. Section 8 – Other Events ITEM 8.01 Other Events Declaration of Dividend On January 29, 2026, the Company announced a cash dividend of $0.36 per share of Class A and Class B Common Stock, payable on February 18, 2026 to stockholders of record as of the close of business on February 10, 2026. Disclosure Channels to Disseminate Information The Company disseminates information to the public about the Company, its products, services and other matters through various channels, including the Company’s website (www.dolby.com), investor relations website (http://investor.dolby.com), SEC filings, press releases, public conference calls and webcasts, in order to achieve broad, non-exclusionary distribution of information to the public. The Company encourages investors and others to review the information it makes public through these channels, as such information could be deemed to be material information. Section 9 - Financial Statements and Exhibits ITEM 9.01 Financial Statements and Exhibits. (d) Exhibits.
Exhibit No.
Description
99.1
Press Release of Dolby Laboratories, Inc. dated January 29, 2026
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DOLBY LABORATORIES, INC.
By:
/s/ Robert Park
Robert Park Senior Vice President and Chief Financial Officer (Principal Financial Officer)
Date: January 29, 2026
2025 Q3 Q3 2025 Earnings
8-K Nov 18, 2025
2025
Q3
Q3 2025 Earnings
8-KNov 18, 2025
0001193125-25-286178
8-K
false 0001308547 0001308547 2025-11-18 2025-11-18
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 18, 2025
DOLBY LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
Delaware
001-32431
90-0199783
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
1275 Market Street San Francisco, CA 94103-1410 (Address of principal executive offices) (Zip Code) (415) 558-0200 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A common stock, $0.001 par value
DLB
The New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
The following information is intended to be furnished under Item 2.02 of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On November 18, 2025, Dolby Laboratories, Inc. (the “Company”) issued a press release announcing its financial results for its fiscal quarter and fiscal year ended September 26, 2025. The full text of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference.
Item 8.01 Other Events
Declaration of Dividend On November 18, 2025, the Company announced a cash dividend of $0.36 per share of Class A and Class B Common Stock, payable on December 10, 2025 to stockholders of record as of the close of business on December 2, 2025. Disclosure Channels to Disseminate Information The Company disseminates information to the public about the Company, its products, services and other matters through various channels, including the Company’s website (www.dolby.com), investor relations website (http://investor.dolby.com), SEC filings, press releases, public conference calls and webcasts, in order to achieve broad, non-exclusionary distribution of information to the public. The Company encourages investors and others to review the information it makes public through these channels, as such information could be deemed to be material information.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
Description
99.1
Press Release of Dolby Laboratories, Inc. dated November 18, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DOLBY LABORATORIES, INC.
By:
/s/ Robert Park
Robert Park Senior Vice President and Chief Financial Officer (Principal Financial Officer)
Date: November 18, 2025
2025 Q2 Q2 2025 Earnings
8-K Jul 31, 2025
2025
Q2
Q2 2025 Earnings
8-KJul 31, 2025
0001193125-25-170537
8-K
false 0001308547 0001308547 2025-07-31 2025-07-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2025
DOLBY LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
Delaware
001-32431
90-0199783
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
1275 Market Street San Francisco, CA 94103-1410 (Address of principal executive offices) (Zip Code) (415) 558-0200 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A common stock, $0.001 par value
DLB
The New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Section 2 - Financial Information
ITEM 2.02
Results of Operations and Financial Condition.
The following information is intended to be furnished under Item 2.02 of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On July 31, 2025, Dolby Laboratories, Inc. (the “Company”) issued a press release announcing its financial results for its fiscal quarter ended June 27, 2025. The full text of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference. Section 8 - Other Events
ITEM 8.01
Other Events
Declaration of Dividend On July 31, 2025, the Company announced a cash dividend of $0.33 per share of Class A and Class B Common Stock, payable on August 20, 2025 to stockholders of record as of the close of business on August 12, 2025. Disclosure Channels to Disseminate Information The Company disseminates information to the public about the Company, its products, services and other matters through various channels, including the Company’s website (www.dolby.com), investor relations website (http://investor.dolby.com), SEC filings, press releases, public conference calls and webcasts, in order to achieve broad, non-exclusionary distribution of information to the public. The Company encourages investors and others to review the information it makes public through these channels, as such information could be deemed to be material information. Section 9 - Financial Statements and Exhibits
ITEM 9.01
Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
Description
99.1
Press Release of Dolby Laboratories, Inc. dated July 31, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DOLBY LABORATORIES, INC.
By:
/s/ Robert Park
Robert Park
Senior Vice President and Chief Financial Officer (Principal Financial Officer)
Date: July 31, 2025
Latest Dolby Laboratories News
DLB Breaking Stock News: Dive into DLB Ticker-Specific Updates for Smart Investing
Compare DLB vs Leading Stocks
See how DLB stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "DLB Dolby Laboratories - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.